The company attributes its success to the launch of the EVOLUTION medial-pivot knee system. The international revenues were also strong.
The company’s hip products accounted for $46.269 million, a 3.2 percent increase over last year. The knee products represented $35.112 million, an 11.6 percent growth over last year. Extremity products represented the largest growth, 14.8 percent over last year, and accounted for $34.752 million of the company’s sales.
The biologic products accounted for $19.935 million, representing a 2.5 percent increase over the fourth quarter of 2009.
Read the financial report release from Wright Medical Group (pdf).
Read other coverage on Wright Medical Group:
– Wright Medical Group Launches EVOLUTION Medial-Pivot Knee System
– Wright Medical Group Receives Approval for Testing Ankle Replacement System
– Wright Medical Group Launches Limited Release of Hammertoe Fixation System
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
